Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

HDL and LDL: Potential New Players in Breast Cancer Development.

Cedó L, Reddy ST, Mato E, Blanco-Vaca F, Escolà-Gil JC.

J Clin Med. 2019 Jun 14;8(6). pii: E853. doi: 10.3390/jcm8060853. Review.

2.

Vitamin B3 impairs reverse cholesterol transport in Apolipoprotein E-deficient mice.

Méndez-Lara KA, Santos D, Farré N, Nan MN, Pallarès V, Pérez-Pérez A, Alonso N, Escolà-Gil JC, Blanco-Vaca F, Julve J.

Clin Investig Arterioscler. 2019 May 13. pii: S0214-9168(19)30047-6. doi: 10.1016/j.arteri.2019.04.001. [Epub ahead of print] English, Spanish.

PMID:
31097214
3.

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.

Martínez-López D, Camafeita E, Cedó L, Roldan-Montero R, Jorge I, García-Marqués F, Gómez-Serrano M, Bonzon-Kulichenko E, Blanco-Vaca F, Blanco-Colio LM, Michel JB, Escola-Gil JC, Vázquez J, Martin-Ventura JL.

EBioMedicine. 2019 May;43:43-53. doi: 10.1016/j.ebiom.2019.04.012. Epub 2019 Apr 11.

4.

Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.

Blanco-Vaca F, Martin-Campos JM, Beteta-Vicente Á, Canyelles M, Martínez S, Roig R, Farré N, Julve J, Tondo M.

Atherosclerosis. 2019 Apr;283:52-60. doi: 10.1016/j.atherosclerosis.2019.01.036. Epub 2019 Feb 11.

PMID:
30782561
5.

Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice.

Méndez-Lara KA, Farré N, Santos D, Rivas-Urbina A, Metso J, Sánchez-Quesada JL, Llorente-Cortes V, Errico TL, Lerma E, Jauhiainen M, Martín-Campos JM, Alonso N, Escolà-Gil JC, Blanco-Vaca F, Julve J.

Int J Mol Sci. 2019 Feb 2;20(3). pii: E655. doi: 10.3390/ijms20030655.

6.

Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm-Brief Report.

Martínez-López D, Cedó L, Metso J, Burillo E, García-León A, Canyelles M, Lindholt JS, Torres-Fonseca M, Blanco-Colio LM, Vázquez J, Blanco-Vaca F, Jauhiainen M, Martín-Ventura JL, Escolà-Gil JC.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2750-2754. doi: 10.1161/ATVBAHA.118.311704.

PMID:
30354236
7.

Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function.

Canyelles M, Tondo M, Cedó L, Farràs M, Escolà-Gil JC, Blanco-Vaca F.

Int J Mol Sci. 2018 Oct 19;19(10). pii: E3228. doi: 10.3390/ijms19103228. Review.

8.

A rare STAP1 mutation incompletely associated with familial hypercholesterolemia.

Blanco-Vaca F, Martín-Campos JM, Pérez A, Fuentes-Prior P.

Clin Chim Acta. 2018 Dec;487:270-274. doi: 10.1016/j.cca.2018.10.014. Epub 2018 Oct 9.

PMID:
30308187
9.

Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting.

Martín-Campos JM, Plana N, Figueras R, Ibarretxe D, Caixàs A, Esteve E, Pérez A, Bueno M, Mauri M, Roig R, Martínez S, Pintó X, Masana L, Julve J, Blanco-Vaca F; Xarxa d’Unitats de Lípids i Arteriosclerosi (XULA).

J Clin Lipidol. 2018 Nov - Dec;12(6):1452-1462. doi: 10.1016/j.jacl.2018.09.002. Epub 2018 Sep 7.

PMID:
30293936
10.

Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Méndez-Lara KA, Santos D, Farré N, Ruiz-Nogales S, Leánez S, Sánchez-Quesada JL, Zapico E, Lerma E, Escolà-Gil JC, Blanco-Vaca F, Martín-Campos JM, Julve J, Pol O.

PLoS One. 2018 Oct 4;13(10):e0204841. doi: 10.1371/journal.pone.0204841. eCollection 2018.

11.

Phytosterols in cancer: From molecular mechanisms to preventive and therapeutic potentials.

Blanco-Vaca F, Cedo L, Julve J.

Curr Med Chem. 2018 Jun 6. doi: 10.2174/0929867325666180607093111. [Epub ahead of print]

PMID:
29874991
12.

Altered HDL Remodeling and Functionality in Familial Hypercholesterolemia.

Cedó L, Plana N, Metso J, Lee-Rueckert M, Sanchez-Quesada JL, Kovanen PT, Jauhiainen M, Masana L, Escolà-Gil JC, Blanco-Vaca F.

J Am Coll Cardiol. 2018 Jan 30;71(4):466-468. doi: 10.1016/j.jacc.2017.11.035. No abstract available.

13.

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.

Cedó L, Santos D, Roglans N, Julve J, Pallarès V, Rivas-Urbina A, Llorente-Cortes V, Laguna JC, Blanco-Vaca F, Escolà-Gil JC.

PLoS One. 2017 Dec 15;12(12):e0189834. doi: 10.1371/journal.pone.0189834. eCollection 2017.

14.

A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia.

Rial-Crestelo D, Santos-Recuero I, Julve J, Blanco-Vaca F, Torralba M.

J Clin Lipidol. 2017 Nov - Dec;11(6):1475-1479.e3. doi: 10.1016/j.jacl.2017.08.008. Epub 2017 Aug 24.

PMID:
28942093
15.

LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.

Errico TL, Méndez-Lara KA, Santos D, Cabrerizo N, Baila-Rueda L, Metso J, Cenarro A, Pardina E, Lecube A, Jauhiainen M, Peinado-Onsurbe J, Escolà-Gil JC, Blanco-Vaca F, Julve J.

Transl Res. 2017 Aug;186:19-35.e5. doi: 10.1016/j.trsl.2017.05.004. Epub 2017 May 18.

PMID:
28583767
16.

Antiatherogenic potential of ezetimibe in sitosterolemia: Beyond plant sterols lowering.

Cedó L, Blanco-Vaca F, Escolà-Gil JC.

Atherosclerosis. 2017 May;260:94-96. doi: 10.1016/j.atherosclerosis.2017.03.034. Epub 2017 Mar 25. No abstract available.

PMID:
28365445
17.

Phytosterol-mediated inhibition of intestinal cholesterol absorption in mice is independent of liver X receptor.

Cedó L, Santos D, Ludwig IA, Silvennoinen R, García-León A, Kaipiainen L, Carbó JM, Valledor AF, Gylling H, Motilva MJ, Kovanen PT, Lee-Rueckert M, Blanco-Vaca F, Escolà-Gil JC.

Mol Nutr Food Res. 2017 Sep;61(9). doi: 10.1002/mnfr.201700055. Epub 2017 Apr 5.

PMID:
28296229
18.

Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.

Chehaibi K, le Maire L, Bradoni S, Escola JC, Blanco-Vaca F, Slimane MN.

Transl Res. 2017 Apr;182:27-48. doi: 10.1016/j.trsl.2016.10.004. Epub 2016 Oct 18.

PMID:
27818230
19.

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.

Cedó L, García-León A, Baila-Rueda L, Santos D, Grijalva V, Martínez-Cignoni MR, Carbó JM, Metso J, López-Vilaró L, Zorzano A, Valledor AF, Cenarro A, Jauhiainen M, Lerma E, Fogelman AM, Reddy ST, Escolà-Gil JC, Blanco-Vaca F.

Sci Rep. 2016 Nov 3;6:36387. doi: 10.1038/srep36387.

20.

Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.

Sánchez-Hernández RM, Civeira F, Stef M, Perez-Calahorra S, Almagro F, Plana N, Novoa FJ, Sáenz-Aranzubía P, Mosquera D, Soler C, Fuentes FJ, Brito-Casillas Y, Real JT, Blanco-Vaca F, Ascaso JF, Pocovi M.

Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.

PMID:
27784735

Supplemental Content

Loading ...
Support Center